McIntyre RS, Rasgon N, Goldberg J, Wong S, Le GH, Mansur RB, Rosenblat JD, Teopiz KM, Stahl SM (2025) The effect of glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide receptor agonists on neurogenesis, differentiation, and plasticity (Neuro-GDP): potential mechanistically informed therapeutics in the treatment and prevention of mental disorders
For example, a patient managing hypertension may find that after six months on oral semaglutide, their weight loss allows them to reduce or even discontinue their blood pressure medications
Support consistent physical activity, adequate sleep, and reduced stress, which together contribute to improved metabolic hormone responses, including GLP-1
doi: 10.1021/acs.jmedchem.7b00174 79 NestorJJZhangXJaw-TsaiSParkesDGBeckerCK
29, 2025 from Wiggs, A